Catheter Precision Inc (AMEX: VTAK) kicked off on Friday, up 18.01% from the previous trading day, before settling in for the closing price of $0.45. Over the past 52 weeks, VTAK has traded in a range of $0.31-$8.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 708.22% over the past five years. While this was happening, its average annual earnings per share was recorded 93.15%. With a float of $7.83 million, this company’s outstanding shares have now reached $8.00 million.
Let’s look at the performance matrix of the company that is accounted for 14 employees. In terms of profitability, gross margin is 90.48%, operating margin of -2704.01%, and the pretax margin is -2928.32%.
Catheter Precision Inc (VTAK) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Catheter Precision Inc is 2.18%, while institutional ownership is 2.02%. The most recent insider transaction that took place on Jan 23 ’24, was worth 5,694. In this transaction Executive Chairman and CEO of this company bought 9,528 shares at a rate of $0.60, taking the stock ownership to the 329,856 shares. Before that another transaction happened on Jan 22 ’24, when Company’s Executive Chairman and CEO bought 9,528 for $0.43, making the entire transaction worth $4,092. This insider now owns 320,328 shares in total.
Catheter Precision Inc (VTAK) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 93.15% per share during the next fiscal year.
Catheter Precision Inc (AMEX: VTAK) Trading Performance Indicators
Take a look at Catheter Precision Inc’s (VTAK) current performance indicators. Last quarter, stock had a quick ratio of 0.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.13, a number that is poised to hit -2.00 in the next quarter and is forecasted to reach -6.30 in one year’s time.
Technical Analysis of Catheter Precision Inc (VTAK)
Catheter Precision Inc (AMEX: VTAK) saw its 5-day average volume 0.75 million, a negative change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 79.29%. Additionally, its Average True Range was 0.06.
During the past 100 days, Catheter Precision Inc’s (VTAK) raw stochastic average was set at 10.05%, which indicates a significant decrease from 87.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.34% in the past 14 days, which was lower than the 221.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4463, while its 200-day Moving Average is $2.5520. Nevertheless, the first resistance level for the watch stands at $0.5841 in the near term. At $0.6383, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7165. If the price goes on to break the first support level at $0.4517, it is likely to go to the next support level at $0.3735. The third support level lies at $0.3193 if the price breaches the second support level.
Catheter Precision Inc (AMEX: VTAK) Key Stats
The company with the Market Capitalisation of 5.00 million has total of 8,005K Shares Outstanding. Its annual sales at the moment are 440 K in contrast with the sum of -70,570 K annual income. Company’s last quarter sales were recorded 100 K and last quarter income was -4,120 K.
